Mestinon
Formulated to address muscle weakness, utilized to support neuromuscular transmission and to relieve fatigue in myasthenia gravis.
- Category
- Neurology
- Active ingredient
- Pyridostigmine
- Supply
- Pharmacy
- Route
- Oral use
- Form
- Tablet
- Strengths
- 60mg
Mestinon details
- Condition
- Myasthenia Gravis
- Therapeutic class
- Acetylcholinesterase Inhibitor
- Pharmacological class
- Parasympathomimetic
- Contraindications
- mechanical intestinal obstruction; urinary tract obstruction; hypersensitivity
- Minor side effects
- nausea; abdominal cramps; diarrhoea
- Moderate side effects
- bradycardia; bronchial secretions; muscle fasciculations
- Dosage forms
- Tablet
- Administration route
- Oral use
- Supply category
- Pharmacist only, dispensed without a prescription
- Manufacturer
- Meda
- Onset Time
- 30–60 minutes
- Duration
- 4–6 hours
- Storage instructions
- Store at room temperature in a dry place.
- Drug interactions
- beta-blockers; aminoglycosides
- Age restrictions
- Suitable for children and adults under specialist guidance.
Precautions and warnings
caution in patients with asthma; monitor for cholinergic crisis; use with care in patients with bradycardia
Serious side effects
cholinergic crisis, requires immediate medical attention; convulsions, requires immediate medical attention
Patient summary
Formulated to address muscle weakness, utilized to support neuromuscular transmission and to relieve fatigue in myasthenia gravis.
Mechanism of action
Pyridostigmine inhibits the enzyme acetylcholinesterase, which breaks down acetylcholine at the neuromuscular junction, thereby increasing the availability of acetylcholine to stimulate muscle contraction.
Pregnancy and breastfeeding
Pregnancy: Use only when strictly necessary. Breastfeeding: Small amounts excreted; monitor infant.
Where this medicine is registered
- Singapore
- Hong Kong
- Thailand
- Malaysia
- Philippines
- Indonesia
- Taiwan
- South Korea
- Japan
- Australia
- New Zealand
- UAE
- South Africa
About Mestinon
Mestinon is the established brand name for pyridostigmine, a treatment used to support better muscle function for patients managing Myasthenia Gravis. Manufactured by Meda, this medication is supplied as a 60mg tablet. Supporting the connection between nerves and muscles helps to manage the symptoms associated with the condition.
Buying Mestinon online
Mestinon is registered across 14 markets, including Thailand, Malaysia and the Philippines, with availability also in Indonesia, Taiwan and South Korea. As Myasthenia Gravis requires consistent daily management, regular access to medicine is a priority for expats living across the region. Generic pyridostigmine, often sourced from India, is far more affordable than the branded version. We provide access to this essential therapy, ensuring that patients across these areas can maintain their routine reliably and affordably.